Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 8, 2007, Pages 3014-3016

  Müller, Frank Michael C ^a   Staudigel, Andrea ^b   Salvenmoser, Stefanie ^a   Tredup, Antje ^a   Miltenberger, Rudolf ^c   Herrmann, Josef V ^c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c Bavarian State Institute for Viticulture and Horticulture   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; FLUQUINCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; PENCONAZOLE; PYRROLE DERIVATIVE; TEBUCONAZOLE; TRIADIMENOL; UNCLASSIFIED DRUG; VORICONAZOLE;

ARTICLE; CANDIDA ALBICANS; CANDIDA ALBIDUS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA LAMBICA; CANDIDA NORVEGENSIS; CANDIDA PARAPSILOSIS; CANDIDA RUGOSA; CANDIDA STELLATA; CROSS RESISTANCE; CRYPTOCOCCUS NEOFORMANS; CYNICLOMYCES GUTTULATUS; FUNGAL STRAIN; GRAPE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OROPHARYNX; PICHIA ANOMALA; PRIORITY JOURNAL; RHODOTORULA; SACCHAROMYCES CEREVISIAE;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIFUNGAL AGENTS; AZOLES; CANDIDA ALBICANS; CANDIDIASIS, ORAL; DRUG RESISTANCE, FUNGAL; ENVIRONMENTAL MICROBIOLOGY; FUNGICIDES, INDUSTRIAL; GERMANY; HIV INFECTIONS; HIV-1; HUMANS; MICROBIAL SENSITIVITY TESTS; OROPHARYNX; VITIS;

EID: 34547629066     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00459-07     Document Type: Article

References (12)

1. Bundesinstitut für gesundheitlichen Verbraucherschutz und Veterinärmedizin. 7 June 2001, posting date. Problematik der Entwicklung von Resistenzen humaner Mykosen gegenüber Azol-Antimykotika und eventueller Wechselwirkungen mit den als Fungizid eingesetzten Pflanzenschutzmitteln. Bundesinstitut für gesundheitlichen Verbraucherschutz und Veterinärmedizin, Berlin, Germany. http://www.bfr.bund.de/cm/218/ problematik_der_entwicklung_von_resistenzen_humaner_mykosen_gegenueber_ azol_antimykotika.pdf/.
2. Goff, D. A., S. L. Koletar, W. J. Buesching, J. Barnishan, and R. J. Fass. 1995. Isolation of fluconazole-resistant Candida albicans from human immunodeficiency virus-negative patients never treated with azoles. Clin. Infect. Dis. 20:77-83.
3. Gupta, A. K., and E. Tomas. 2003. New antifungal agents. Dermatol. Clin. 21:565-576.
4. Ji, H., W. Zhang, Y. Zhou, M. Zhang, J. Zhu, Y. Song, and J. Lu. 2000. A three-dimensional model of lanosterol 14alpha-demethylase of Candida albicans and its interaction with azole antifungals. J. Med. Chem. 43:2493-2505.
5. Leen, C. L., E. M. Dunbar, M. E. Ellis, and B. K. Mandal. 1990. Once-weekly fluconazole to prevent recurrence of oropharyngeal candidiasis in patients with AIDS and AIDS-related complex: a double-blind placebo-controlled study. J. Infect. 21:55-60.
6. Müller, F. M., M. Weig, J. Peter, and T. J. Walsh. 2000. Azole cross-resistance to ketoconazole, fluconazole, itraconazole and voriconazole in clinical Candida albicans isolates from HIV-infected children with oropharyngeal candidosis. J. Antimicrob. Chemother. 46:338-340.
7. NCCLS. 2002. Reference method for broth dilution antifungal susceptibility testing of yeasts; M27-A2, vol. 17, no. 9. NCCLS, Wayne, PA.
8. Ng, T. T., and D. W. Denning. 1993. Fluconazole resistance in Candida in patients with AIDS: a therapeutic approach. J. Infect. 26:117-125.
9. Odds, F. C., N. A. Gow, and A. J. Brown. 2001. Fungal virulence studies come of age. Genome Biol. 2:REVIEWS1009.
10. Rowen, J. L., J. M. Tate, N. Nordoff, L. Passarell, and M. R. McGinnis. 1999. Candida isolates from neonates: frequency of misidentification and reduced fluconazole susceptibility. J. Clin. Microbiol. 37:3735-3737.
11. Ruhnke, M., A. Eigler, I. Tennagen, B. Geiseler, E. Engelmann, and M. Trautmann. 1994. Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection. J. Clin. Microbiol. 32:2092-2098.
12. White, T. C., S. Holleman, F. Dy, L. F. Mirels, and D. A. Stevens. 2002. Resistance mechanisms in clinical isolates of Candida albicans. Antimicrob. Agents Chemother. 46:1704-1713.